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Varicella-zoster virus (VZV) is a ubiquitous and highly conta-gious human α-herpesvirus. Upon primary infection, VZV causes chickenpox (varicella) in susceptible individuals and 
establishes lifelong latency in sensory ganglia1–3. Chickenpox exerts 
a considerable disease burden worldwide, with an estimated annual 
minimum of 140 million new cases, 4.2 million severe complica-
tions leading to hospitalization, and 4,200 deaths4. VZV reactivates 
from latency in almost one-third of infected individuals later in life 
to cause shingles (herpes zoster), which is often characterized by 
severe pain and followed by post-herpetic neuralgia, substantially 
affecting patients’ quality of life5–7. Both chickenpox and shingles 
can lead to severe life-threatening complications7–10. VZV is the 
only human herpesvirus for which a licensed live attenuated vac-
cine, vOka, has been developed and widely administrated in several 
countries for decades11. VZV has also been used as an experimental 
vaccine vector against various pathogens12, including human immu-
nodeficiency virus (HIV)13–16, and for the treatment of cancer17,18.
VZV has a double-stranded DNA (dsDNA) genome with a size 
of approximately 125 kb, which is the smallest among all known 
human herpesviruses and is about half that of human cytomega-
lovirus (HCMV). VZV is known for its extremely low titre in cul-
tured cells and its cell-associated nature—that is, lack of secretion of 
mature virions to the culture supernatant19–22. These characteristics 
of VZV have been attributed to the diversion of newly formed viri-
ons to late endosomal or pre-lysosomal compartments, where they 
are degraded before exocytosis, producing a large proportion of 
coreless and pleomorphic-enveloped particles22,23. Therefore, grow-
ing and isolating mature VZV virions for high-resolution structural 
studies is challenging and, to our knowledge, no structure informa-
tion has been reported for VZV particles. This is in contrast to the 
recently reported near-atomic structures of other members of the 
human herpesvirus family, including the α-herpesviruses herpes 
simplex virus type 1 (HSV-1)24,25 and HSV-226,27, the β-herpesviruses 
HCMV28 and human herpesvirus 6B (HHV-6B)29, and the 
γ-herpesvirus Kaposi’s sarcoma-associated herpesvirus (KSHV)30,31.
In this study, we used a sub-particle reconstruction method to 
work with minimally purified VZV sample and determined the 
structures of VZV capsids at near-atomic resolution by cryo-electron 
microscopy (cryo-EM). Atomic models built on the basis of these 
structures show that, compared with other human herpesviruses, 
VZV has a similarly sized capsid consisting of herpesvirus-conserved 
subunits, but with fewer intra- and inter-capsid protein interactions 
and less stably associated tegument proteins. VZV-specific struc-
tural features have been characterized and should offer insights into 
the mechanism of VZV capsid assembly and pathogenesis.
Results
Characterization and overall structure of VZV A- and C-capsids. 
Uniquely among human herpesviruses, VZV is highly cell-associated 
and grows to very low titre in cell culture, presenting a major 
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Varicella-zoster virus (VZV) is a medically important human herpesvirus that causes chickenpox and shingles, but its 
cell-associated nature has hindered structure studies. Here we report the cryo-electron microscopy structures of purified VZV 
A-capsid and C-capsid, as well as of the DNA-containing capsid inside the virion. Atomic models derived from these struc-
tures show that, despite enclosing a genome that is substantially smaller than those of other human herpesviruses, VZV has a 
similarly sized capsid, consisting of 955 major capsid protein (MCP), 900 small capsid protein (SCP), 640 triplex dimer (Tri2) 
and 320 triplex monomer (Tri1) subunits. The VZV capsid has high thermal stability, although with relatively fewer intra- and 
inter-capsid protein interactions and less stably associated tegument proteins compared with other human herpesviruses. 
Analysis with antibodies targeting the N and C termini of the VZV SCP indicates that the hexon-capping SCP—the largest 
among human herpesviruses—uses its N-terminal half to bridge hexon MCP subunits and possesses a C-terminal flexible half 
emanating from the inner rim of the upper hexon channel into the tegument layer. Correlation of these structural features and 
functional observations provide insights into VZV assembly and pathogenesis and should help efforts to engineer gene delivery 
and anticancer vectors based on the currently available VZV vaccine.
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challenge for obtaining large amounts of mature virions for struc-
tural studies. We purified VZV capsids from whole-cell lysates 
of ARPE-19 cells infected by VZV (parental Oka (P-Oka) strain) 
(see a thin section examined by transmission electron microscopy 
in Extended Data Fig. 1a–c) in the presence of 1% Triton X-100 
and 1 M KCl by sucrose-cushion ultracentrifugation. The purified 
capsids primarily consisted of naked A-capsids (empty particles, 
about 94%) and C-capsids (containing the viral genome, about 
6%), and B-capsids (with a scaffold core) were barely observed 
(Extended Data Fig. 1d). From these particles, we determined the 
three-dimensional (3D) icosahedral reconstructions of the A- and 
C-capsids at resolutions of 4.3 and 5.3 Å, respectively. These recon-
structions show nearly identical structures of the capsids (Fig. 1a,b, 
Supplementary Table 1 and Supplementary Video 1), but differ in 
the inner densities (Fig. 1c). Unexpectedly, the capsid-associated 
tegument complex (CATC) is absent on both A- and C-capsids, an 
observation confirmed by both structural (Fig. 1a,b) and biochemi-
cal (Extended Data Fig. 2) analyses.
To improve resolution, a sub-particle reconstruction strategy 
was used24,26,32. In brief, sub-particles of capsid areas around the 
three-fold symmetry axis were re-extracted and corrected for local 
defocus. Symmetry expansion and refinement of contrast transfer 
function were then applied to sub-particles for final reconstruc-
tions. The resolutions of sub-particle reconstructions of A-capsid 
and C-capsid were improved to 3.5 and 4.1 Å, respectively (Fig. 1d, 
Extended Data Fig. 3 and Supplementary Table 1). High-resolution 
features resolved in our cryo-EM maps, such as the polypeptide 
backbone and amino acid side chains (Fig. 1e and Extended Data 
Figs. 4 and 5), enabled us to build atomic models for both capsid 
types (Extended Data Fig. 6). Within an asymmetric unit, our mod-
els include 15 conformers of the MCP pORF40 in 2.5 hexons, one 
penton MCP, 15 conformers of the SCP pORF23 atop the 2.5 hex-
ons, and 5 heterotrimeric triplexes (Ta, Tb, Tc, Td, and Te), each 
consisting of two conformers of the Tri2 pORF41 and one of the 
Tri1 pORF20 (Fig. 1f). The asymmetric unit also contains one-third 
of triplex Tf at the location of the three-fold symmetry axis, but the 
details of Tf were smeared by icosahedral averaging, precluding 
atomic modelling. The upper domain of the penton MCP was only 
resolved at a lower resolution, probably due to flexibility, and was 
not modelled (Fig. 1f). The models of asymmetric units of A- and 
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Fig. 1 | Cryo-eM reconstructions and atomic modelling of the VZV a- and C-capsids. a,b, Radially coloured VZV A-capsid (a) and C-capsid (b) 
reconstructions at resolutions of 4.3 and 5.3 Å, respectively. Maps are viewed along a three-fold symmetry axis. The five-, three- and two-fold axes are 
denoted in the C-capsid reconstruction by a black pentagon, triangle and oval, respectively. c, Central slices of the VZV A-capsid (left) and C-capsid 
(right). The C-capsid slice shows interlayer dsDNA densities within the capsid shell. d,e, Localized reconstruction at 3.5 Å resolution of three-fold 
sub-particles in A-capsids (d) and a close-up view of the density map (grey mesh) of an α-helix in the MCP floor region, superposed with its model (e).  
f, Models of individual capsid proteins in ribbon representation in rainbow, from the N terminus (blue) to the C terminus (red).
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C-capsids are similar, as indicated by their root mean square devia-
tion of 0.76 Å over 25,884 aligned Cα positions of the two models 
(Extended Data Fig. 6).
Structure of the MCP. The 1,396-residue MCP constitutes the pen-
ton and, together with SCP, all the hexons of VZV. Our model of 
the hexon MCP can be partitioned into seven domains following 
the nomenclature of HCMV28: upper (residues 495 to 1065), chan-
nel (424 to 494 and 1342 to 1380), buttress (1123 to 1351), helix–
hairpin (205 to 241), dimerization (304 to 389), N-lasso (1 to 70) 
and Johnson fold (71 to 194, 238 to 294, 372 to 406 and 1048 to 
1122) (Fig. 2a and Supplementary Video 2). The most prominent 
difference between VZV and other herpesviruses in hexon MCP 
is its flexibility at the dimerization domain (residues 349 to 374). 
Furthermore, the penton MCP of VZV is highly flexible for its upper 
and N-lasso domains (Fig. 2b). The VZV hexon has a larger internal 
diameter of ~17 Å (Fig. 2c) compared with those in other herpes-
viruses (~10 to 12 Å)24,26,28. Similar to other herpesviruses24,26,28,31,33, 
three types of MCP–MCP interactions (type I, II and III interac-
tions) on the VZV capsid floor form a hierarchical level of network 
interactions (Extended Data Fig. 7) and a noncovalent chainmail. 
The interactions between hexon MCPs are similar to those in HSV-1 
capsids. However, our structure shows that the penton–hexon inter-
actions of VZV are much less extensive compared with those of 
HSV (strong helix–helical interactions)24, HCMV (buttress support 
reinforcement)28 and KSHV (six-stranded β-sheet interactions and 
buttress domain related interactions)31 (Fig. 2d,e). The helix pair 
interactions in HSV-1 have been suggested to stabilize pentons and 
serve to buttress the pentons against the internal pressure of pack-
aged DNA24. The high flexibility in the dimerization domain and 
consequently, the lack of helical interactions (or type II and type 
III interactions), at the floor of VZV pentons probably accounts for 
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Fig. 2 | MCP organization and pentonal MCP–hexonal MCP interactions. a, Canonical hexon MCP coloured and labelled by domain. b, Superposition of 
hexon and penton MCPs. c, Pipe-and-plank depiction of an E hexon showing the central channel (dashed square). The narrowest region has a dimension  
(Φ) of about 17 Å. d, Part of the MCP–MCP interaction network viewed from the outside. e, Comparisons of MCP interactions between hexons and pentons 
in the capsids of VZV, HSV-1, HCMV and KSHV.
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their structural instability, and the relatively less stable binding of 
CATCs on the penton vertexes of VZV capsids (see below).
Structure of the triplex and its interactions with MCPs. Amid 
the canyons formed by three neighbouring capsomeres is a triplex, 
consisting of one Tri1 and two Tri2 conformers (denoted as Tri2A 
and Tri2B) (Fig. 3a–d). The VZV triplex, which adopts a trimeric 
arrangement in the quasi-three-fold symmetrical environment 
(Fig. 3a), shares common structural features with triplexes of other 
herpesviruses but possesses more flexible regions (Tri1 residues 1 to 
118 and 371 to 385, Tri2A 162 to 178, and Tri2B 1 to 3, 164 to 172 and 
250 to 267). The less rigid structure of the VZV triplex may result 
from its lack of inter- or intra-molecular disulfide bond formation 
compared with those reported in HSV-124 (Supplementary Fig. 1). 
Tri2A and Tri2B both contain two domains—trunk (142 to 288) 
and embracing arm (1 to 141 and 289 to 316)—but the embracing 
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Fig. 4 | Structure of the VZV virion showing the CaTC and dsDNa genome. a,b, Radially coloured reconstructions of the VZV C-capsid (a) and virion 
(b). CATC is absent on VZV naked C-capsids (a) but present on capsids inside virions (b). c, Sub-particle classification of virion capsid penton vertexes 
shows that CATCs bind only half (class 1), while the rest (class 2–4) lack bound CATCs. d, Western blot showing a gradual loss of VZV CATC components 
(c1 and c2) from the virion pellets by detergent lysis (Triton X-100 (TX-100)) in the presence of increasing KCl concentrations (0, 0.1, 0.2, 0.5 and 1 M). 
Experiments were performed three times independently with similar results. e, Radially coloured central slab of the VZV A-capsid (without internal 
density) and virion (with dsDNA density inside). At least three layers of dsDNA duplex with a 30 Å inter-duplex distance are recognizable, and part of 
the outer layer density bends and reaches into the hexon channels. f–h, Central sections of an E hexon from the density map of VZV (f), HSV26 (g) and 
HCMV28 (h), showing partial insertion, no insertion and deep insertion, respectively, of genomic DNA into the space (marked by ellipses) inside the capsid 
hexon channels. i–k, Central sections showing electrostatic surface potential of the capsid hexon channels of VZV (i), HSV (j) and HCMV (k). Blue and 
red denote positive and negative charges, respectively. Orange dashed circles mark the inner entrance to the hexon channel. The viral dsDNA at the hexon 
channel entrance is schematically indicated by the green solid line.
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arms, which interact with each other, exhibit structural diver-
sity between Tri2A and Tri2B (Fig. 3b–d). The N-anchor domain 
(1 to 117) of Tri1 is highly flexible, and only smeared densities are 
observed, which are inserted inside the capsid with a tri-lobed struc-
ture, anchoring the entire triplex (Fig. 3a,e,f). Extensive interactions 
exist between the triplex and three buttress arms extending from the 
three surrounding MCPs (Fig. 3g,h). Similar buttress arms involv-
ing triplex–MCP interactions have also been observed in HCMV, 
which appear to clamp the triplex more stably because the distal 
extremity of the buttress arm of HCMV contains a helix (which is 
a loop in VZV), thus forming stronger helix–helical interactions28.
VZV-specific features in the CATC and packaged genome. For 
HSV, the hetero-pentameric CATCs, which form extensive inter-
action networks with the capsid proteins, have been implicated in 
the stabilization and intracellular transport of the capsids24,27,34,35. 
However, CATCs were not observed in the purified VZV C-capsids, 
which raises the question of whether CATCs bind the capsid in 
intact VZV virions. Despite extreme difficulties due to associa-
tion of VZV with its host cells, we attempted to purify intact VZV 
virions for structural analysis. We obtained 3,447 particle images 
of intact VZV virions from more than 16,000 cryo-EM micro-
graphs (Extended Data Fig. 1e) and, from these images, computed 
a final icosahedral reconstruction at a resolution of 6.3 Å (Extended 
Data Fig. 3 and Supplementary Table 1). This virion capsid recon-
struction at an intermediate resolution reveals unlike in the naked 
C-capsid, CATCs are present on the five-fold vertex of virion capsids 
(Fig. 4a,b). However, the CATC densities are much lower than for 
other capsid proteins (Fig. 4b), indicating that the binding sites of 
CATCs on VZV capsids are not fully saturated. Further sub-particle 
classification focused on penton vertexes shows that only about half 
(50.5%) of pentons are bound with CATCs (Fig. 4c). These results 
suggest low occupancy or relative flexibility of CATCs in VZV viri-
ons or a combination of both.
To characterize the binding of CATCs biochemically, VZV viri-
ons were treated with 1% Triton X-100 and different concentrations 
of KCl and then ultracentrifuged for western blot analysis (Fig. 4d 
and Extended Data Fig. 8a). Following Triton X-100 treatment, viri-
ons still contained substantial amounts of tegument, while increas-
ing KCl from 0.1 to 0.5 or 1 M extracted several tegument proteins 
from viral capsids, including the putative CATC components 
pORF43 and pORF34, which are homologues of pUL17 and pUL25 
of HSV-1, respectively. By contrast, the CATC of HSV-1 (exempli-
fied by pUL17) was resistant to the same treatment and remained 
associated with capsids (Extended Data Fig. 8b), as also reported 
previously36,37. These data suggest that the CATC of VZV may bind 
to the capsid via relatively weaker interactions, and is easily dis-
carded during the capsid purification process involving detergent 
and KCl treatment.
dsDNA in the virion capsid is packaged as regularly spaced dense 
shells with a larger interlayer distance of ~30 Å, distinguishing them 
from those of HSV (~25–26 Å) and HCMV (~23 Å) (Fig. 4e). The 
VZV genome densities show less ordered packing than those of 
HSV and HCMV and have only three to four recognizable layers, 
probably due to its small genomic size (Fig. 4e). Unexpectedly, the 
outmost layer of the VZV genome seems to partially occupy the 
narrow interior confines of the capsid’s hexon channel (Fig. 4f), 
similar to that of HCMV with a 235 kb genome, but unlike that of 
HSV (Fig. 4g,h). This observation appears to counter the argument 
for more space being needed to accommodate the large HCMV 
genome, as VZV has a much smaller genome. A comparison of 
the surface charge properties of hexon channels among these her-
pesviruses indicates that, although they are mainly neutral for the 
HSV hexon channel, residues lining the hexon channel entrance of 
both VZV and HCMV are positively charged (Fig. 4i–k). Moreover, 
those deep inside the channel become negatively charged in VZV 
(Fig. 4i), but remain positive in HCMV (Fig. 4k). Thus, the reach 
of surface residues with a positive charge, complementary to that 
of the dsDNA genome, is correlated with the extent of the DNA 
inserted into these channels (Fig. 4f–k), suggesting that electrostatic 
interactions rather than genome sizes influence DNA distribution 
inside the hexon channels.
VZV-specific features in the SCP. Ranging from 8 to 35 kDa 
in molecular mass, the smallest capsid proteins vary the most in 
size across herpesviruses, whereas the largest capsid proteins, the 
150 kDa MCPs, vary the least. The 235-residue SCP of VZV is the 
largest among human herpesviruses, with a unique C terminus 
(residues 108 to 235; Supplementary Fig. 1), and is essential for 
VZV infection of human skin tissues in vivo38. This prompted us 
to investigate the role of the SCP in VZV. Unlike those in β- and 
γ-herpesviruses but similar to those in the α-herpesviruses HSV-
139, HSV-240 and pseudorabies virus (PrV)41, VZV SCP caps hex-
ons but not pentons (Fig. 1d), interfacing between the capsid and 
the tegument. To investigate its role in VZV assembly, we prepared 
antibodies targeted to the N terminus (Ab-SCPn, targeting residues 
1–15) and C terminus (Ab-SCPc, targeting residues 108–235) of 
the VZV SCP. Western blot analysis using these antibodies showed 
that purified VZV capsids contained the full-length SCP (~35 kDa; 
Fig. 5a). However, our cryo-EM structure only shows ordered den-
sities of the N-terminal region of SCP, and the densities of its C ter-
minus are smeared (Fig. 5b). To our knowledge, these disordered 
C-terminal densities—which emanate from the inner rim of the 
upper hexon channel and project into the tegument layer—have 
not been observed in other herpesviruses, although they disap-
pear when increasing the threshold of the map (σ from 0.25 to 3.00; 
Fig. 5c). These observations suggest that the C-terminal segment 
of SCP (residues 108 to 235) is highly flexible. The model of the N 
terminus (residues 3 to 107) of SCP was then built out; it exhibits 
structural similarity to HSV-1 VP26, with a helix-rich domain (resi-
dues 8 to 75) involved in MCP binding, along with a long insertion 
hairpin-loop domain (residues 76 to 107) to stabilize MCP binding 
Fig. 5 | Characterization and structure of the SCP and its interactions with MCPs. a, Western blot analysis of SCP on VZV capsids (cap) using antibodies 
raised to target either the N terminus (Ab-SCPn) or C terminus (Ab-SCPc) of pORF23. Lysates of uninfected (−) or VZV-infected (+) cells were used as 
negative and positive controls, respectively. Molecular mass markers (in kDa) are shown on the left. Experiments were performed two times independently 
with similar results. b–d, Localized reconstruction of an E hexon of the A-capsid shown with different density thresholds. MCPs and SCPs are coloured in 
cyan and yellow, respectively. b, The lower threshold display of the map shows an extra density blob (grey) emanating from the last modelled residue of 
both the N-terminal end (residue 8) and C-terminal end (residue 107) of each SCP subunit. c, When the map is displayed at the higher threshold of three 
standard deviations (σ) above the mean, both density blobs disappear, suggesting flexibility of the N-terminal 7 residues and C-terminal 127 residues. 
d, Purple dashed lines in the model simulate disordered C termini of SCP on the basis of the extra densities as shown in b. e, Atomic model of an SCP 
monomer shown as ribbons, rainbow-coloured from the N terminus (blue) to the C terminus (red). The flexible C-terminal extension is depicted as a 
dashed line, and the binding sites of antibodies are indicated by the schematic drawing of Y-shaped antibodies (Ab-SCPn, blue; Ab-SCPc, red). f, The 
SCP bridging two underlying MCPs (MCP C3 and C4). g, Cross-linking of six SCP subunits forms a gear-shaped hexameric ring crowning each hexon. 
h,i, Interaction details of SCPs with MCPs. h, The hairpin-loop of SCP C3 inserts into a groove formed by MCP C4 and SCP C4. i, Open-book view of the 
electrostatic potential surfaces of SCP C3 and MCP C3 shows their complementary electrostatic surface charges.
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(Fig. 5d,e). Similar to HSV, six SCP subunits form a gear-shaped 
hexameric ring crowning each hexon, with their hairpin-loop 
domains filling in the gap between adjacent hexon MCP upper 
domains (Fig. 5f–h). The SCPs cross-link each other and cap hexons 
via two types of interactions: (1) the insertion loop extends into the 
groove formed by the upper domains of two adjacent hexon SCPs, 
forming hydrophobic interactions. The N terminus of the adjacent 
SCP also interacts with the insertion loop and stabilizes the inser-
tion (Fig. 5h); (2) residues of the connection loop (residues 76 to 
79), together with a part of the stem helix (residues 67 to 75), are 
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positively charged and electrostatically interact with the negatively 
charged MCP upper region (residues 865 to 883 and 908 to 915; 
Fig. 5i). These noncovalent cross-linking and capping interactions 
of SCPs and MCP–SCP resemble those of the 112-amino-acid SCP 
homologue VP26 in HSV-1 and HSV-2, and may have a similar 
function in stabilizing the hexons.
Discussion
The lack of structural information about the VZV particles repre-
sents both a knowledge gap in understanding VZV capsid assembly 
and an untapped opportunity for structure-based rational design of 
VZV-based vectors for prophylactic and therapeutic applications. 
We present here the near-atomic-resolution structure of the VZV 
capsid. The overall structure is highly similar to those of HSV-1 and 
HSV-2 but has some specific features, such as more regions with 
flexibility in pentons and triplexes, as well as SCP C terminus densi-
ties. Furthermore, the structure shows that the VZV capsid is orga-
nized by weaker or less extensive interactions compared with capsids 
of other herpesviruses, including penton–hexon, triplex–MCP, and 
even CATC–capsid interactions. Unlike the numerous disulfide 
bonds observed in HSV-1 capsids, there is a general lack of disulfide 
bonding in the VZV capsid. On the basis of these observations, it is 
tempting to speculate that the VZV capsid has relatively lower stabil-
ity. Nonetheless, the VZV capsid is sufficiently stable, as indicated by 
our thermal stability assay (Extended Data Fig. 9) showing that VZV 
capsids withstood high temperatures (up to 87 °C), similar to HSV-1 
capsids (up to 86 °C) and by the fact that high-resolution structures 
were obtained by averaging many particles.
Herpesviruses assemble a similarly sized capsid but have diverse 
capsid-fortifying strategies to ensure encapsidation of their differ-
ently sized genomes, overcoming up to tens of atmospheres of inter-
nal pressure due to compacted dsDNA genome42,43. Our structures 
reveal that, although the VZV capsid tends to have fewer links and 
more flexibility, most of its structure and the capsomer–capsomer 
interaction networks within the structure generally resemble those 
of other herpesviruses. Thus, we speculate that the high stability of 
VZV capsids is derived from the intrinsic structural features of her-
pesvirus capsids. Moreover, due to the smaller genomic DNA and 
therefore lower internal pressure, the VZV capsid may enable fewer 
or weaker intra-subunit and inter-subunit interactions to maintain 
structural stability. Conversely, we have identified increased struc-
tural flexibility in pentons, triplexes and the SCP C terminus of VZV 
capsids compared with solved structures of mostly tegumented cap-
sids from the mature virions of other herpesviruses. Whether these 
features are unique to VZV or associated with the structural pertur-
bation caused by purification steps should be further confirmed by 
solving high-resolution structures of VZV capsids in intact virions, 
which remains challenging.
CATCs binding at capsid vertices of herpesviruses could 
enhance capsid stability27,28,44,45. Similar to their homologues in 
HSV, all three subunits of VZV CATC are essential for viral rep-
lication46. Occupancy of CATC binding sites on virion capsids 
is ~50% in VZV (Fig. 4c), compared with near 100% in the other 
α-herpesviruses HSV-124, HSV-227 and PrV47. Moreover, VZV 
CATC dissociated from the capsid when treated with detergent and 
at high KCl concentration (Fig. 4d); by contrast, HSV-1 CATC was 
resistant to the same treatment (Extended Data Fig. 8). Our results 
also showed high thermal stability of the VZV C-capsids without 
CATCs (Extended Data Fig. 9). Together, these results suggest a 
diminished role, if any, for VZV CATC in stabilizing the pressur-
ized DNA-containing capsids. Interestingly, similar low occupancy 
of peri-penton CATC binding sites has been observed in the virions 
of the γ-herpesviruses KSHV31,44 and Epstein–Barr virus (EBV) (see 
also the accompanying Article48), although their peri-portal CATC 
binding sites are fully occupied, pointing to conserved functions of 
CATC in facilitating DNA packaging and ejection.
The capsids of all herpesviruses have the same protein composi-
tions for their capsid shell: MCP, SCP, Tri1 and Tri2. Among them, 
SCP is the smallest and the most divergent, both structurally and 
functionally, across different subfamilies of the Herpesviridae, and 
even within the α-herpesvirus subfamily. The VZV SCP is 2.1 times 
the size of the SCP homologues in the α-herpesviruses HSV-1 and 
HSV-2, about 3 times that of the β-herpesviruses HCMV28 and 
HHV-6B29, and about 1.4 times that of the γ-herpesviruses KSHV30,31 
and EBV (Supplementary Fig. 1). Similar to SCP homologues in 
HSV-1 and HSV-224,26, six copies of VZV SCP form a ring crowning 
only hexons, compared with those in β- and γ-herpesviruses, which 
bind both hexons and pentons28,31. Relevant to chickenpox and 
shingles, SCP was shown to be essential for VZV growth in human 
fetal skin xenografts in a SCID humanized mice model in vivo, and 
in melanoma cells in vitro38. By contrast, SCPs were proved to be 
nonessential for replication of HSV-1 and PrV49,50. Similar to that of 
VZV, SCPs of HCMV and KSHV are required for viral growth51,52. 
Further studies on structure–function relationships should provide 
insights into the molecular basis for the specific roles of SCPs in the 
replication of different herpesviruses. For VZV, SCP interacts with 
MCP to facilitate its nuclear translocation, suggesting a role in the 
process of capsid assembly38. The MCP-bound N-terminal region 
of SCP (residues 8 to 107) appears to serve as the capsid anchor 
of SCP’s flexible C-terminal segment (residues 108 to 235), which 
is unique among human herpesviruses. With this long C terminus 
projecting up from the capsid surface (Fig. 5b–d), the VZV SCP is 
probably involved in functional interactions with other viral or host 
factors. Indeed, previous yeast two-hybrid studies have shown that 
VZV SCP interacts with components of the nuclear egress complex, 
including pORF24 and pORF27 (homologues of pUL34 and pUL31 
of HSV-1, respectively), as well as the tegument proteins pORF7, 
pORF9 and pORF21 (homologues of pUL51, VP22 and pUL37 of 
HSV-1, respectively)53–55. These findings suggest possible alternative 
roles for SCP in the nuclear egress and secondary envelopment of 
VZV particles.
Overall, the near-atomic structures of VZV capsids reported 
here, together with the previously reported cryo-EM structures of 
HSV capsids, reveal structural similarities and differences among 
these human α-herpesviruses and provide insights into their 
capsid-assembly mechanisms. Interaction hotspots revealed in our 
structures could be targeted either for designing competitive inhibi-
tors as antivirals or for engineering live attenuated VZV strains as 
vaccines against chickenpox and shingles. Moreover, as it has the 
smallest genome size among human herpesviruses and high capsid 
stability, safe VZV vectors based on the commercially available live 
VZV vaccine could be engineered to carry exogenous DNA frag-
ments as platforms for development of multivalent vaccines and 
anticancer agents.
Methods
Cells. Human retinal pigment epithelial ARPE-19 cells (CRL-2302) and African 
green monkey Vero kidney cells (CCL-81) were obtained from the American 
Type Culture Collection and maintained in DMEM containing 10% fetal bovine 
serum, penicillin/streptomycin and l-glutamine. Mouse SP2/0-Ag14 myeloma 
cells (GDC0019) were obtained from the China Center for Type Culture Collection 
and maintained in RPMI 1640 medium containing 10% fetal bovine serum, 
penicillin/streptomycin and l-glutamine. The cell lines were authenticated by the 
providers using morphology, karyotyping and PCR-based approaches and were 
not further authenticated in our laboratory. Cells tested negative for Mycoplasma 
contamination by PCR before use in experiments.
VZV particle preparation. ARPE-19 cells were infected with the wild-type 
parental Oka strain (P-Oka) of VZV at a multiplicity of infection (MOI) of 0.3 
when reaching ~80% confluence. For VZV capsid purification, infected cells were 
collected at 3 d post infection (dpi) with the cytopathic effect reaching >80%, 
resuspended in ice-cold lysis buffer (PBS containing 1% Triton X-100, 1 M KCl and 
protease inhibitor) and incubated on ice for 30 min. After lysis, large cell debris 
was removed from the solution by centrifugation at 1,500g at 4 °C for 15 min. 
Then, the capsids were pelleted through a 30% (w/v in PBS) sucrose cushion 
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by centrifugation at 110,000g at 4 °C for 15 min in a Beckman SW28 rotor and 
resuspended in PBS for cryo-EM sample preparation and other experiments.
For VZV virion purification, VZV-infected ARPE-19 cells were collected 
when showing >80% cytopathic effect and were homogenized with a Dounce 
homogenizer for 20–30 strokes. The clarified cytoplasmic extract was centrifuged 
at 1,500g at 4 °C for 15 min to remove large cell debris. The resulting solution was 
centrifuged through a linear 20% to 50% (w/v in PBS) sucrose gradient at 110,000g 
at 4 °C for 1 h in a Beckman SW28 rotor. The lower visible band was collected, 
diluted in PBS and centrifuged through a 30% (w/v in PBS) sucrose cushion at 
110,000g at 4 °C for 15 min. The pelleted crude VZV virions were resuspended  
in PBS and subsequently subjected to cryo-EM sample preparation and  
other experiments.
HSV-1 particle preparation. Vero cells were infected with the KOS strain of 
HSV-1 at an MOI of 0.01. At 3 dpi, the cells and culture medium were collected 
for purification of naked capsids and intact virions, respectively. HSV-1 capsids 
were purified from whole-cell lysate using the same method as for VZV capsid 
purification. HSV-1 virions were purified using the method described previously, 
with slight modification24. In brief, after removal of large cell debris, the culture 
medium was centrifuged at 80,000g for 1 h. Pellets were resuspended in PBS and 
then centrifuged through a linear 20% to 50% (w/v) sucrose density gradient at 
80,000g for 1 h. The upper band was collected, diluted with PBS and pelleted by 
centrifuging at 80,000g for 1 h. The pelleted HSV-1 virions were resuspended in 
PBS and frozen at −80 °C before use.
Antibodies. To obtain antibodies against the capsid proteins (pORF40, pORF41, 
pORF20 and pORF23 of VZV and HSV-1 VP5), the portal protein (VZV 
pORF54) and the CATC proteins (pORF34 and pORF43 of VZV, and HSV-1 
pUL25), BALB/c mice were immunized subcutaneously with the corresponding 
recombinant viral proteins (100 μg) or synthetic peptides conjugated to bovine 
serum albumin (BSA, 100 μg) emulsified in complete Freund’s adjuvant and 
boosted twice, at two week intervals, with the same doses of antigen in incomplete 
Freund’s adjuvant. Two weeks after the final boost, splenic cells from immunized 
mice were fused with SP2/0-Ag14 myeloma cells and the hybridoma supernatants 
were screened using an enzyme-linked immunosorbent assay (ELISA) against each 
antigen. Finally, antibodies were purified from mouse ascitic fluid using protein A 
affinity columns. All animal experimental protocols were approved by the Xiamen 
University Laboratory Animal Center and were conducted in strict compliance 
with the guidelines of the Xiamen University Institutional Committee for Care and 
Use of Laboratory Animals (approval code: XMULAC20160049). Additionally, 
antibodies against pORF9, pORF62 and gE of VZV were prepared previously56,57, 
and antibodies against ICP4, VP16, and gD of HSV-1 were purchased from Santa 
Cruz Biotechnology.
Western blot analysis. Purified viral particles and lysates prepared from 
mock-infected or VZV or HSV-1-infected cells were separated by 10% SDS–PAGE, 
and proteins were then transferred to nitrocellulose membranes. After blocking 
for 1 h, membranes were incubated for 1 h with primary mouse antibodies against 
the capsid proteins (pORF40, pORF41, pORF20 and pORF23 of VZV, and HSV-1 
VP5), the portal protein (VZV pORF54), the CATC proteins (pORF34 and pORF43 
of VZV, and HSV-1 pUL25), the viral glycoproteins (VZV gE and HSV-1 gD), 
and other tegument proteins (pORF9 and pORF62 of VZV, and ICP4 and VP16 
of HSV-1) at a concentration of 1 μg ml. Then, the membranes were incubated 
with horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody 
at a dilution of 1:5,000 for 30 min, and finally protein bands were visualized by 
chemiluminescence. All procedures were conducted at room temperature.
Particle-stability thermal-release assay. Thermofluor experiments were 
performed with a CFX86 PCR instrument (Bio-rad). The fluorescent dyes 
SYTO-Green and SYTO9 (Thermo Fisher Scientific) were used to detect the 
presence of DNA and RNA, respectively. Each 50 μl reaction was set up in a 
thin-walled PCR plate containing 1.0 μg of purified capsids of VZV or HSV-1 
and 5 μM SYTO-Green or SYTO9 in PBS. The temperature was ramped from 45 
to 99 °C and the fluorescence was recorded in triplicate at 0.5 °C intervals. The 
negative first derivatives of the fluorescence change (−d(RFU)/dT, where RFU is 
relative fluorescence units and T represents time) were plotted against temperature.
Transmission electron microscopy. ARPE-19 cells infected with VZV P-Oka 
strain (at an MOI of 0.3) were collected at 3 dpi and prepared for transmission 
electron microscopy analysis as previously described58,59. In brief, samples were 
fixed in 2.5% glutaraldehyde in phosphate buffer (0.1 M, pH 7.4), post-fixed 
with 1% osmium tetroxide, incubated in 1% aqueous uranyl acetate overnight, 
dehydrated through graded ethanol and embedded with an Embed 812 kit 
(Electron Microscopy Sciences). Ultra-thin sections were stained with 3.5% 
aqueous uranyl acetate and 0.2% lead citrate. Images were recorded using a Tecnai 
G2 Spirit transmission electron microscope (FEI).
Cryo-EM imaging. A 3 μl aliquot of purified VZV capsids or virion was applied 
to freshly glow-discharged holey carbon Quantifoil Cu grids (R2/2, 200 mesh, 
Quantifoil Micro Tools), and then blotted for 6 s before plunge-freezing the grids 
into liquid ethane cooled by liquid nitrogen inside a Vitrobot Mark IV (Thermo 
Fisher Scientific) at 100% humidity and 4 °C. The cryo-grids were initially checked 
at 300 kV with the FEI Tecnai F30, with only good quality grids selected for 
data collection. Cryo-EM images of naked capsids were acquired with the FEI 
Titan Kiros (Thermo Fisher Scientific) with a Gatan K2 Summit direct electron 
detector at a nominal ×130,000 magnification, corresponding to a calibrated 
physical pixel size of 1.305 Å (0.6525 Å for superresolution pixel size). Each movie 
had 40 frames, with a total dose of 56 e– Å−2 with an exposure time of 8 s. Data 
were semi-automatically collected using SerialEM60. Cryo-EM images of virions 
were acquired with the FEI Tecnai F30 with a Falcon III direct electron detector 
(Thermo Fisher Scientific) at a nominal magnification of ×59,000, corresponding 
to a pixel size of 1.76 Å. A total electron dose of about 40 e– Å−2 was fractionated 
into 39 frames in every movie at an exposure time of 1 s. Data were automatically 
collected with Thermo Fisher EPU software.
Image processing and 3D reconstruction. Drift and beam-induced motion 
correction was performed with MotionCor261 to produce a micrograph from 
each movie. Contrast transfer function fitting and phase-shift estimation 
were conducted with Gctf62. Micrographs with astigmatism, obvious drift or 
contamination were discarded before reconstruction. Particles were automatically 
picked and screened using cisTEM63. The initial 3D models for each dataset were 
generated with a random model method using AUTO3DEM64. Several rounds of 
reference-free 2D classifications and unsupervised 3D classifications were executed 
using Relion 2.165. Sorted particles were then subjected to final homogenous 
refinement using Relion 2.1 and cisTEM. The resolution of all density maps was 
determined by the gold-standard Fourier shell correlation curve, with a cut-off of 
0.14366. Local map resolution was estimated with ResMap67.
To improve the resolution, we used Relion symmetry expansion to exact and 
perform sub-particle reconstruction as previously described32. In brief, after 3D 
refinement with imposition of icosahedral symmetry, we extracted sub-particles 
from the three-fold region in a box-size of 540 × 540 pixels and expanded 
the sub-particles with I1 symmetry. The extracted sub-particles were used to 
generate the initial model using Relion relion_reconstruct command. Further 
3D classification and refinement were performed by Relion 2.1 and cisTEM. The 
resolution was assessed by Fourier shell correlation curves with a cut-off at 0.143 
from two independent half-sets of the sub-particles.
Atomic model building, refinement and 3D visualization. As the upper domain 
of the pentonal MCP exhibited very weak densities, we built the model only for 
the middle and floor regions. The initial VZV capsid model was generated from 
homology modelling on the basis of the atomic model of HSV-124 using Accelrys 
Discovery Studio software (https://www.3dsbiovia.com). We initially fitted the 
templates into the corresponding segmented volume (enclosing an asymmetric 
unit) of the final cryo-EM maps using Chimera68, and further corrected and 
adjusted them manually by real-space refinement in Coot69. The resulting models 
were then refined with phenix.real_space_refine in PHENIX70. These operations 
were executed iteratively until the problematic regions, Ramachandran outliers 
and poor rotamers were either eliminated or moved to the favoured regions. 
After several cycles of refinement, the resulting models were fitted into the map 
of six neighbouring asymmetric units. The totality of these seven asymmetric 
units were subjected to further real-space refinement to optimize the clashes. The 
final atomic models were validated with Molprobity71. Structure-based sequence 
alignment was performed with Clustal Omega on the EBI server (https://www.
ebi.ac.uk/Tools/msa/clustalo/). For the intermolecular interactions, maximum 
cut-off distances of 4.0 Å were used for hydrogen bonding, salt-bridge formation 
and other contacts. All figures were generated with Chimera or Pymol software 
(http://www.pymol.org).
Reporting Summary. Further information on research design is available in the 
Nature Research Reporting Summary linked to this article.
Data availability
Structure coordinates have been deposited in the Protein Data Bank under 
accession numbers 6LGL (A-capsid) and 6LGN (C-capsid). The corresponding 
electron microscopy density maps have been deposited in the Electron Microscopy 
Data Bank under accession numbers EMD-0880 (icosahedral reconstruction of 
the A-capsid), EMD-0881 (icosahedral reconstruction of the C-capsid), EMD-
30251 (icosahedral reconstruction of the virion capsid), EMD-30248 (localized 
reconstruction of the A-capsid) and EMD-30250 (localized reconstruction of the 
C-capsid). Source data are provided with this paper.
Received: 2 January 2020; Accepted: 3 August 2020;  
Published: xx xx xxxx
References
 1. Schmid, D. S. & Jumaan, A. O. Impact of varicella vaccine on varicella-zoster 
virus dynamics. Clin. Microbiol. Rev. 23, 202–217 (2010).
NaTuRe MiCRobioLogY | www.nature.com/naturemicrobiology
Articles NATurE MiCrobiology
 2. Arvin, A. M. Varicella-zoster virus. Clin. Microbiol. Rev. 9, 361–381 (1996).
 3. Ross, A. H. Modification of chicken pox in family contacts by administration 
of gamma globulin. N. Engl. J. Med. 267, 369–376 (1962).
 4. World Health Organization. Varicella and herpes zoster vaccines: WHO 
position paper, June 2014. Wkly. Epidemiol. Rec. 89, 265–287 (2014).
 5. Lukas, K., Edte, A. & Bertrand, I. The impact of herpes zoster and 
post-herpetic neuralgia on quality of life: patient-reported outcomes in six 
European countries. Z. Gesundh. Wiss. 20, 441–451 (2012).
 6. Johnson, R. W. et al. The impact of herpes zoster and post-herpetic neuralgia 
on quality-of-life. BMC Med. 8, 37 (2010).
 7. Gilden, D. H., Kleinschmidt-DeMasters, B. K., LaGuardia, J. J., Mahalingam, 
R. & Cohrs, R. J. Neurologic complications of the reactivation of 
varicella-zoster virus. N. Engl. J. Med. 342, 635–645 (2000).
 8. Pergam, S. A., Limaye, A. P. & AST Infectious Diseases Community of 
Practice. Varicella zoster virus in solid organ transplantation: guidelines from 
the American Society of Transplantation Infectious Diseases Community of 
Practice. Clin. Transplant. 33, e13622 (2019).
 9. Bozzola, E. & Bozzola, M. Varicella complications and universal 
immunization. J. Pediatr. 92, 328–330 (2016).
 10. Gnann, J. W. Jr. Varicella-zoster virus: atypical presentations and unusual 
complications. J. Infect. Dis. 186(Suppl 1), S91–S98 (2002).
 11. Quinlivan, M. & Breuer, J. Clinical and molecular aspects of the live 
attenuated Oka varicella vaccine. Rev. Med. Virol. 24, 254–273 (2014).
 12. Cohen, J. I. The varicella-zoster virus genome. Curr. Top. Microbiol. Immunol. 
342, 1–14 (2010).
 13. Staprans, S. I. et al. Enhanced SIV replication and accelerated progression to 
AIDS in macaques primed to mount a CD4 T cell response to the SIV 
envelope protein. Proc. Natl Acad. Sci. USA 101, 13026–13031 (2004).
 14. Willer, D. O. et al. Experimental infection of cynomolgus macaques (Macaca 
fascicularis) with human varicella-zoster virus. J. Virol. 86, 3626–3634 (2012).
 15. Perciani, C. T. et al. Protocol of a randomised controlled trial characterising 
the immune responses induced by varicella-zoster virus (VZV) vaccination in 
healthy Kenyan women: setting the stage for a potential VZV-based HIV 
vaccine. BMJ Open 7, e017391 (2017).
 16. Perciani, C. T. et al. Live attenuated varicella-zoster virus vaccine does not 
induce HIV target cell activation. J. Clin. Invest. 129, 875–886 (2019).
 17. Landmeier, S. et al. Gene-engineered varicella-zoster virus reactive CD4+ 
cytotoxic T cells exert tumor-specific effector function. Cancer Res. 67, 
8335–8343 (2007).
 18. Tanaka, M. et al. Vaccination targeting native receptors to enhance the 
function and proliferation of chimeric antigen receptor (CAR)-modified 
T cells. Clin. Cancer Res. 23, 3499–3509 (2017).
 19. Carpenter, J. E., Hutchinson, J. A., Jackson, W. & Grose, C. Egress of light 
particles among filopodia on the surface of varicella-zoster virus-infected 
cells. J. Virol. 82, 2821–2835 (2008).
 20. Cook, M. L. & Stevens, J. G. Labile coat: reason for noninfectious cell-free 
varicella-zoster virus in culture. J. Virol. 2, 1458–1464 (1968).
 21. Harson, R. & Grose, C. Egress of varicella-zoster virus from the melanoma 
cell: a tropism for the melanocyte. J. Virol. 69, 4994–5010 (1995).
 22. Gershon, A. A. et al. Intracellular transport of newly synthesized 
varicella-zoster virus: final envelopment in the trans-Golgi network. J. Virol. 
68, 6372–6390 (1994).
 23. Chen, J. J., Zhu, Z., Gershon, A. A. & Gershon, M. D. Mannose 6-phosphate 
receptor dependence of varicella zoster virus infection in vitro and in the 
epidermis during varicella and zoster. Cell 119, 915–926 (2004).
 24. Dai, X. & Zhou, Z. H. Structure of the herpes simplex virus 1 capsid with 
associated tegument protein complexes. Science 360, eaao7298 (2018).
 25. Liu, Y. T., Jih, J., Dai, X., Bi, G. Q. & Zhou, Z. H. Cryo-EM structures of 
herpes simplex virus type 1 portal vertex and packaged genome. Nature 570, 
257–261 (2019).
 26. Yuan, S. et al. Cryo-EM structure of a herpesvirus capsid at 3.1 Å. Science 
360, eaao7283 (2018).
 27. Wang, J. et al. Structure of the herpes simplex virus type 2 C-capsid with 
capsid-vertex-specific component. Nat. Commun. 9, 3668 (2018).
 28. Yu, X., Jih, J., Jiang, J. & Zhou, Z. H. Atomic structure of the human 
cytomegalovirus capsid with its securing tegument layer of pp150. Science 
356, eaam6892 (2017).
 29. Zhang, Y. et al. Atomic structure of the human herpesvirus 6B capsid and 
capsid-associated tegument complexes. Nat. Commun. 10, 5346 (2019).
 30. Gong, D. et al. DNA-packing portal and capsid-associated tegument 
complexes in the tumor herpesvirus KSHV. Cell 178, 1329–1343 (2019).
 31. Dai, X. et al. Structure and mutagenesis reveal essential capsid protein 
interactions for KSHV replication. Nature 553, 521–525 (2018).
 32. Ilca, S. L. et al. Localized reconstruction of subunits from electron 
cryomicroscopy images of macromolecular complexes. Nat. Commun. 6,  
8843 (2015).
 33. Zhou, Z. H. et al. Four levels of hierarchical organization, including 
noncovalent chainmail, brace the mature tumor herpesvirus capsid against 
pressurization. Structure 22, 1385–1398 (2014).
 34. Cardone, G. et al. The UL36 tegument protein of herpes simplex virus 1 has a 
composite binding site at the capsid vertices. J. Virol. 86, 4058–4064 (2012).
 35. Grunewald, K. et al. Three-dimensional structure of herpes simplex virus 
from cryo-electron tomography. Science 302, 1396–1398 (2003).
 36. Wolfstein, A. et al. The inner tegument promotes herpes simplex virus capsid 
motility along microtubules in vitro. Traffic 7, 227–237 (2006).
 37. Radtke, K. et al. Plus- and minus-end directed microtubule motors bind 
simultaneously to herpes simplex virus capsids using different inner tegument 
structures. PLoS Pathog. 6, e1000991 (2010).
 38. Chaudhuri, V., Sommer, M., Rajamani, J., Zerboni, L. & Arvin, A. M. 
Functions of varicella-zoster virus ORF23 capsid protein in viral replication 
and the pathogenesis of skin infection. J. Virol. 82, 10231–10246 (2008).
 39. Zhou, Z. H. et al. Assembly of VP26 in herpes simplex virus-1 inferred from 
structures of wild-type and recombinant capsids. Nat. Struct. Biol. 2, 
1026–1030 (1995).
 40. Huet, A. et al. Extensive subunit contacts underpin herpesvirus capsid 
stability and interior-to-exterior allostery. Nat. Struct. Mol. Biol. 23,  
531–539 (2016).
 41. Liu, Y. T. et al. A pUL25 dimer interfaces the pseudorabies virus capsid and 
tegument. J. Gen. Virol. 98, 2837–2849 (2017).
 42. Bauer, D. W., Huffman, J. B., Homa, F. L. & Evilevitch, A. Herpes virus 
genome, the pressure is on. J. Am. Chem. Soc. 135, 11216–11221 (2013).
 43. Brandariz-Nunez, A., Liu, T., Du, T. & Evilevitch, A. Pressure-driven release 
of viral genome into a host nucleus is a mechanism leading to herpes 
infection. eLife 8, e47212 (2019).
 44. Dai, X., Gong, D., Wu, T. T., Sun, R. & Zhou, Z. H. Organization of 
capsid-associated tegument components in Kaposi’s sarcoma-associated 
herpesvirus. J. Virol. 88, 12694–12702 (2014).
 45. Snijder, J. et al. Vertex-Specific Proteins pUL17 and pUL25 Mechanically 
Reinforce Herpes Simplex Virus Capsids. J. Virol. 91, e00123-17 (2017).
 46. Zhang, Z. et al. Genome-wide mutagenesis reveals that ORF7 is a novel VZV 
skin-tropic factor. PLoS Pathog. 6, e1000971 (2010).
 47. Homa, F. L. et al. Structure of the pseudorabies virus capsid: comparison with 
herpes simplex virus type 1 and differential binding of essential minor 
proteins. J. Mol. Biol. 425, 3415–3428 (2013).
 48. Liu, W. et al. Structures of capsid and capsid-associated tegument complex 
inside the Epstein–Barr virus. Nat. Microbiol. https://doi.org/10.1038/
s41564-020-0758-1 (2020).
 49. Desai, P., DeLuca, N. A. & Person, S. Herpes simplex virus type 1 VP26 is 
not essential for replication in cell culture but influences production of 
infectious virus in the nervous system of infected mice. Virology 247, 
115–124 (1998).
 50. Krautwald, M., Maresch, C., Klupp, B. G., Fuchs, W. & Mettenleiter, T. C. 
Deletion or green fluorescent protein tagging of the pUL35 capsid component 
of pseudorabies virus impairs virus replication in cell culture and 
neuroinvasion in mice. J. Gen. Virol. 89, 1346–1351 (2008).
 51. Borst, E. M., Mathys, S., Wagner, M., Muranyi, W. & Messerle, M. Genetic 
evidence of an essential role for cytomegalovirus small capsid protein in viral 
growth. J. Virol. 75, 1450–1458 (2001).
 52. Perkins, E. M. et al. Small capsid protein pORF65 is essential for  
assembly of Kaposi’s sarcoma-associated herpesvirus capsids. J. Virol. 82, 
7201–7211 (2008).
 53. Uetz, P. et al. Herpesviral protein networks and their interaction with the 
human proteome. Science 311, 239–242 (2006).
 54. Stellberger, T. et al. Improving the yeast two-hybrid system with permutated 
fusions proteins: the varicella zoster virus interactome. Proteome Sci. 8,  
8 (2010).
 55. Wang, W. et al. Varicella-zoster virus ORF7 interacts with ORF53 and plays a 
role in its trans-Golgi network localization. Virol. Sin. 32, 387–395 (2017).
 56. Liu, J. et al. Serological evaluation of immunity to the varicella-zoster virus 
based on a novel competitive enzyme-linked immunosorbent assay. Sci. Rep. 
6, 20577 (2016).
 57. Jiang, H. F. et al. ORF7 of varicella-zoster virus is required for viral 
cytoplasmic envelopment in differentiated neuronal cells. J. Virol. 91, 
e00127–00117 (2017).
 58. Selariu, A. et al. ORF7 of varicella-zoster virus is a neurotropic factor. J. Virol. 
86, 8614–8624 (2012).
 59. Wang, W. et al. Outer nuclear membrane fusion of adjacent nuclei in 
varicella-zoster virus-induced syncytia. Virology 512, 34–38 (2017).
 60. Mastronarde, D. N. SerialEM: A program for automated tilt series acquisition 
on Tecnai microscopes using prediction of specimen position. Microsc. 
Microanal. 9, 1182–1183 (2003).
 61. Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced 
motion for improved cryo-electron microscopy. Nat. Methods 14,  
331–332 (2017).
 62. Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 
193, 1–12 (2016).
 63. Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for 
single-particle image processing. eLife 7, e35383 (2018).
NaTuRe MiCRobioLogY | www.nature.com/naturemicrobiology
ArticlesNATurE MiCrobiology
 64. Yan, X., Sinkovits, R. S. & Baker, T. S. AUTO3DEM—an automated and  
high throughput program for image reconstruction of icosahedral particles.  
J. Struct. Biol. 157, 73–82 (2007).
 65. Kimanius, D., Forsberg, B. O., Scheres, S. H. & Lindahl, E. Accelerated 
cryo-EM structure determination with parallelisation using GPUs in 
RELION-2. eLife 5, e18722 (2016).
 66. Scheres, S. H. & Chen, S. Prevention of overfitting in cryo-EM structure 
determination. Nat. Methods 9, 853–854 (2012).
 67. Kucukelbir, A., Sigworth, F. J. & Tagare, H. D. Quantifying the local 
resolution of cryo-EM density maps. Nat. Methods 11, 63–65 (2014).
 68. Pettersen, E. F. et al. UCSF Chimera—a visualization system for exploratory 
research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
 69. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. 
Acta Crystallogr. D 60, 2126–2132 (2004).
 70. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for 
macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
 71. Chen, V. B. et al. MolProbity: all-atom structure validation for 
macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
acknowledgements
Single-particle cryo-EM data were collected at the Center of Cryo-Electron Microscopy 
at Zhejiang University. We thank X. Zhang and S. Chang for support with facility access 
and data acquisition. This research was supported by grants from the National Science 
and Technology Major Projects for Major New Drugs Innovation and Development 
(no. 2018ZX09711003-005-003), the National Science and Technology Major Project of 
Infectious Diseases (no. 2017ZX10304402), the National Natural Science Foundation of 
China (no. 81871648, 81601762), the Research Unit of Frontier Technology of Structural 
Vaccinology of Chinese Academy of Medical Sciences (no. 2019RU022) and the US 
National Institutes of Health (DE025567/028583). The funders had no role in the study 
design, data collection and analysis, decision to publish or preparation of the manuscript.
author contributions
T.C., Z.H.Z., H.Z., S.L. and N.X. conceived and designed this project; D.P., W.F., X.Y., 
J.H., J.L. and Y.C. prepared the samples; Q.Z., H.Y., M.H., R.Z., Y.H., Z.Z and Z.C. 
performed data acquisition, image processing and structure determination; W.W., 
D.P., W.F., J.L. and Y.Q. prepared the antibodies. W.W, D.P. and Y.C. performed the 
immunological analysis. All authors participated in the data analysis and manuscript 
preparation.
Competing interests
The authors declare no competing interests.
additional information
Extended data is available for this paper at https://doi.org/10.1038/s41564-020-0785-y.
Supplementary information is available for this paper at https://doi.org/10.1038/
s41564-020-0785-y.
Correspondence and requests for materials should be addressed to S.L., H.Z., Z.H.Z., 
T.C. or N.X.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in 
published maps and institutional affiliations.
© The Author(s), under exclusive licence to Springer Nature Limited 2020
NaTuRe MiCRobioLogY | www.nature.com/naturemicrobiology
Articles NATurE MiCrobiology
Extended Data Fig. 1 | electron microscopic imaging of VZV particles. a–c, Representative electron microscopic images of VZV-infected ARPE-19 cells 
recorded at 3 days post-infection (dpi) using a Tecnai G2 Spirit transmission electron microscope. Panel a shows VZV nucleocapsids in the nucleus of an 
infected cell. Intact capsids are indicated by black arrow heads, and capsids without an electron-dense core are indicated by white arrow heads. Panel  
b,c show enveloped viral particles (blue arrows) within cytoplasmic vacuoles and on the surface of infected cells, respectively. Insets show enlarged 
images of the boxed areas. Experiments were performed two times independently with similar results. Nu and Cy indicate the nucleus and cytoplasm, 
respectively. Scale bars in a–c denote 0.5 μm, 1 μm and 1 μm, respectively. d, Purified VZV naked particles were recorded using a Gatan K2 Summit direct 
electron detector, showing two types of particles in our sample preparation: DNA-containing C-capsid and DNA-devoid A-capsid. Experiments were 
performed two times independently with similar results. e, Purified VZV virions were recorded using a Falcon3 direct electron detector. Experiments were 
performed two times independently with similar results. Scale bars in d,e denote 50 nm.
NaTuRe MiCRobioLogY | www.nature.com/naturemicrobiology
ArticlesNATurE MiCrobiology
Extended Data Fig. 2 | immunoblot characterization of purified VZV capsids. VZV capsids (c) were purified from the infected ARPE-19 cells at 3 dpi and 
were analyzed by western blot using antibodies against the indicated viral proteins. Lysates of uninfected (-) and VZV-infected (+) cells were used as 
negative and positive controls, respectively. Molecular mass markers in kilodaltons (kDa) are shown on the left. Experiments were performed two times 
independently with similar results. pORF43 and pORF34 of VZV are homologs of pUL17 and pUL25 of HSV-1, respectively, and represent two putative 
components (c1 and c2) of VZV CATC.
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Extended Data Fig. 3 | global and local resolution analysis of 3D reconstructions of VZV a-capsid and C-capsid. a, Fourier shell correlation (FSC) 
of global and localized reconstructions of three kinds of purified VZV particles. Resolutions were determined using a reference-based FSC coefficient 
criterion of 0.143. b,c, Maps from localized reconstructions of A- (b) and C-capsid (c) were analyzed by Resmap.
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Extended Data Fig. 4 | Density maps and atomic models of MCP and SCP. The fitted models of MCP and SCP are colored in green and blue, respectively. 
Insets correspond to zoomed-in views of boxed regions and illustrate residue features in the density map (mesh).
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Extended Data Fig. 5 | Density maps and atomic models of Tri1 (a), Tri2a (b) and Tri2b (c). Insets correspond to zoomed-in views of boxed regions and 
illustrate residue features in the density map (mesh).
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Extended Data Fig. 6 | Structural comparison of a-capsid and C-capsid. Superposition of the asymmetric units of A-capsid (magenta) and C-capsid 
(cyan) shows highly structural similarity. The models of asymmetric units of A- and C-capsid show high similarity with root mean square deviation of 
0.76 Å over 25,884 aligned Cα positions.
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Extended Data Fig. 7 | Hexon MCP-involved network interactions. a,b, Part of the MCP-MCP interaction network viewed from the outside (a) or inside 
(b) of VZV A-capsid. c,d, Three types of interactions among hexon MCPs are shown. Type I interactions are intracapsomeric augmentations of β-strands 
from adjacent MCPs (P2 and P3 in c). Type II and type III interactions are intercapsomeric interactions among two pairs of MCPs (P2–P3 and C5–C6 in d).
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Extended Data Fig. 8 | See next page for caption.
NaTuRe MiCRobioLogY | www.nature.com/naturemicrobiology
Articles NATurE MiCrobiology
Extended Data Fig. 8 | immunoblot characterization of virion capsids of VZV and HSV-1 after Triton X-100 lysis and KCl treatment. Purified virions 
of VZV (a) and HSV-1 (b) were not treated (no lysis) or treated with 1% Triton X-100 in the presence of 0, 0.1, 0.5, or 1 M KCl. Viral lysates were then 
centrifuged through a 30% sucrose cushion. Pelleted (pellet) and released (supernatant) fractions were analyzed by SDS-PAGE and immunoblotting with 
antibodies targeting the CATC component (comp.) (VZV pORF43 and its HSV-1 counterpart, pUL17), MCP (VZV pORF40 and its HSV-1 counterpart, 
VP5), glycoproteins (VZV gE and HSV-1 gD), and other tegument proteins (TP; VZV pORF62 and pORF9, HSV-1 VP16 and ICP4). Markers of protein 
molecular mass (MW) are indicated in kDa on the right side of the panel. Experiments were performed two times independently with similar results.
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Extended Data Fig. 9 | Particle stability thermal release assay of purified VZV and HSV-1 capsids. Purified capsids (a mixture of A-, B- and C-capsids) 
of VZV (a) and HSV-1 (b) were subjected to the thermofluor stability assay using the dyes SYTO-Green and SYTO9 to detect DNA and RNA exposures, 
respectively. The average negative first derivative of the fluorescence (measured in triplicate) with respect to temperature (−d(RFU)/dT) is shown.
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